Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $30.29 - 0.1
July 26, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q1 2017 Investor Presentation

Annual Reports

Download Documentation 2016 Annual Report to Stockholders

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Medical Appoints Dr. Thomas F. O’Donnell, Jr. as Chief Medical Officer

July 11, 2017

MINNEAPOLIS, July 11, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Tactile Medical to Release Second Quarter 2017 Financial Results on August 7, 2017

July 6, 2017

MINNEAPOLIS, July 06, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Upcoming Events

Q2 2017 Tactile Systems Technology, Inc. Earnings Conference Call
Monday, August 7, 2017 5:00 p.m. ET
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet